Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Late-life semaglutide treatment slows ageing and extends lifespan in female mice
Nature, 2026
Where the Future Lies: GLP-1 Receptor Agonists as Therapeutics for Dermatologic Comorbidities
Clinics in dermatology, 2026
Brca1 heterozygosity leads to hepatic steatosis in male and female mice despite sexually dimorphic effects on systemic metabolism
Metabolism: clinical and experimental, 2026;:156758
Pharmacological management of obesity: Current landscape and emerging therapies
Indian journal of pharmacology, 2026;58(5):505-512
Integrating the liver into the cardiovascular-kidney-metabolic syndrome: pathophysiology and therapeutic implications
Current opinion in nephrology and hypertension, 2026
Multi-Database Pharmacovigilance Analysis of Gastroesophageal Reflux Disease Associated with GLP-1 Receptor Agonists: A Cross-National Signal Validation Study
Gut and liver, 2026
Cardiometabolic outcomes of once-weekly IcoSema in adults with type 2 diabetes: systematic review and meta-analysis of the COMBINE trials
Cardiovascular diabetology. Endocrinology reports, 2026;12(1)
Impact of surfactants on the stability of therapeutic peptides under interfacial stress
Journal of pharmaceutical sciences, 2026;:104493
Patulous Eustachian tube dysfunction following rapid weight loss associated with semaglutide use: A case report
SAGE open medical case reports, 2026;14:2050313X261486164
Combination GLP-1RA and Low-Dose IL-2 Modulates Peripheral Immune Activation and Attenuates CNS Inflammatory Transcript Signatures In Vivo
International journal of molecular sciences, 2026;27(17)
Recent Studies on the Effectiveness and Safety of Anti-Obesity Medications: A Scoping Review
Diabetes, metabolic syndrome and obesity : targets and therapy, 2026;19:626279
Comparative Efficacy of Tirzepatide Versus Semaglutide for Weight Loss in Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis of Head-to-Head Studies
Clinical obesity;16(5):e70111
Weight Regain Trajectories After Discontinuation of Semaglutide or Tirzepatide: A Reconstructed Aggregate-Data Bayesian Longitudinal Meta-Analysis
Endocrinology, diabetes & metabolism;9(5):e70325
In adults with early uncontrolled T2D, tirzepatide vs. intensified conventional care reduced HbA1c levels and weight at 2 y
Annals of internal medicine, 2026
Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review
Annals of internal medicine, 2026
Incretin-based therapies in diabetic kidney disease: toward integrated cardio-kidney-metabolic disease modification
Kidney research and clinical practice, 2026
Trends in GLP-1-Based Therapy Use Before and After Pregnancy
Diabetes, obesity & metabolism, 2026
Incretin-Based Therapies as Cardiometabolic Interventions: Outcome Hierarchy, Receptor-Network Pharmacology and Phenotype-Based Clinical Positioning
Diabetes, obesity & metabolism, 2026
Higher semaglutide dose is associated with lower neuropsychiatric event incidence independent of weight loss
npj metabolic health and disease, 2026;4(1)
GLP-1 receptor agonist exposure and non-arteritic anterior ischaemic optic neuropathy: an illustrative case
Clinical & experimental optometry, 2026;:1-6